Dianthus Therapeutics DNTH
NASDAQ DNTH
$88.21 -0.11 (-0.12%)
At close: Oct 2, 2026 · 4:00 PM EDT

Dianthus Therapeutics (DNTH) Cash & Current Investments (2017 - 2025)

Updated

Dianthus Therapeutics (DNTH) posted Cash & Current Investments of $50.25 million for Q4 2025, up 129.0% from $21.95 million a year earlier but down 8.6% from the prior quarter.

Analysis

Dianthus Therapeutics (DNTH) Cash & Current Investments (2017 - 2025) Analysis & Trends

Since Q2 2017, Dianthus Therapeutics has reported Cash & Current Investments for 34 quarters.

  • Annual Cash & Current Investments shows a five-year compound annual growth rate of -19.5% (FY2020 to FY2025).
  • In prior years, Dianthus Therapeutics' Cash & Current Investments was $21.95 million in FY2024 (-83.3%), $131.19 million in FY2023 (+73.8%), $75.49 million in FY2022 (-57.3%) and $176.93 million in FY2021 (+18.9%).
  • Quarterly Cash & Current Investments has run from a low of $9.25 million in Q1 2025 to a high of $377.04 million in Q1 2024 over five years.
  • On a year-over-year basis, Cash & Current Investments increased in four of the last eight quarters, with growth averaging 123.1%.
  • The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q1 2024, with growth of 612.8%; the weakest was Q1 2025, with a decline of 97.5%.
  • According to Business Quant data, Cash & Current Investments for the three prior quarters was $54.99 million (Q3 2025), $11.95 million (Q2 2025) and $9.25 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Dianthus Therapeutics 3.78 Bn 3.73 Bn - 50.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 50.25 Mn
Sep 30, 2025 54.99 Mn
Jun 30, 2025 11.95 Mn
Mar 31, 2025 9.25 Mn
Dec 31, 2024 21.95 Mn
Sep 30, 2024 281.12 Mn
Jun 30, 2024 360.71 Mn
Mar 31, 2024 377.04 Mn
Dec 31, 2023 131.19 Mn
Sep 30, 2023 189.87 Mn
Jun 30, 2023 55.24 Mn
Mar 31, 2023 52.90 Mn
Dec 31, 2022 75.49 Mn
Sep 30, 2022 106.14 Mn
Jun 30, 2022 139.43 Mn
Mar 31, 2022 156.60 Mn
Dec 31, 2021 176.93 Mn
Sep 30, 2021 192.62 Mn
Jun 30, 2021 207.81 Mn
Mar 31, 2021 132.29 Mn
API Access

Dianthus Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=DNTH&period=max&api_key=YOUR_API_KEY